Commentary: Practicing on the Tip of an Information Iceberg? Evidence of Underpublication of Registered Clinical Trials in Oncology
Authors:
Open Access
- 1 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 13 (9) , 925-929
Abstract
Objective.: Members of the International Committee of Medical Journal Editors require, as a condition of consideration for publication, that all clinical trials be registered in a public trials registry. We evaluated the proportion of registered trials that are published in the peer-reviewed literature. Methods.: After downloading the contents of the National Institutes of Health's ClinicalTrials.gov registry, we used key words to identify trials in oncology. We then evaluated the proportion of trials that had been published in journals listed in PubMed.gov. Among trials with published results, we determined the proportion that reported positive versus negative results. Results.: Among the 2,028 trials meeting the inclusion criteria, 17.6% were available in PubMed. Twenty-one percent of the trials registered before September 1, 2004 were published, compared with 11.9% of those registered after this date. Trials sponsored by clinical trial networks published the greatest proportion of registered studies (59.0%); studies sponsored by industry published the fewest (5.9%). Among published studies, 64.5% reported the results as positive findings. Conclusions.: Less than one in five studies in cancer that are registered with clinicaltrials.gov have been published in peer-reviewed journals. Research sponsors, researchers, and journal editors should redouble their efforts to encourage publication of registered clinical trials in oncology.Keywords
Funding Information
- National Cancer Institute (R25 CA 92408)
This publication has 19 references indexed in Scilit:
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsJournal of Clinical Oncology, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyNew England Journal of Medicine, 2008
- Clinical Trial Registration — Looking Back and Moving AheadNew England Journal of Medicine, 2007
- Optimal Adjuvant Therapy for Non-Small Cell Lung Cancer—How to Handle Stage I DiseaseThe Oncologist, 2007
- Negative Data From Lung Cancer Trial May Change Practice Guidelines, Study DesignsJNCI: Journal of the National Cancer Institute, 2006
- Selective Reporting Biases in Cancer Prognostic Factor StudiesJNCI: Journal of the National Cancer Institute, 2005
- Evidence of publication bias in clinical trials of biotherapies for solid tumorsCancer, 2005
- A Taxpayer-Funded Clinical Trials Registry and Results DatabasePLOS Medicine, 2004
- Public Registration of Clinical TrialsNew England Journal of Medicine, 2004
- Publication Bias and Dissemination of Clinical ResearchJNCI: Journal of the National Cancer Institute, 1989